Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q1 2024 vs. Q4 2023
How the institutions holding Kiora Pharmaceuticals Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 15 | 24 | +9 |
| Shares | 302.7K | 11.1M | +10.8M (+3,581.8%) |
| Value | $159.5K | $7.87M | +$7.71M (+4,833.4%) |
New holders (11)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rosalind Advisors, Inc. | 2,300,000 | $1.62M | 1.52% |
| AIGH Capital Management LLC | 2,300,000 | $1.62M | 0.78% |
| Alyeska Investment Group, L.P. | 2,200,000 | $1.55M | 0.01% |
| Nantahala Capital Management, LLC | 1,900,000 | $1.34M | 0.13% |
| Velan Capital Investment Management LP | 1,100,000 | $776.6K | 0.42% |
| ADAR1 Capital Management, LLC | 1,100,000 | $776.6K | 0.21% |
| XTX Topco Ltd | 24,909 | $17.6K | 0.00% |
| HRT Financial LP | 22,864 | $16.0K | 0.00% |
| Two Sigma Investments, LP | 10,351 | $7.31K | 0.00% |
| FMR LLC | 7 | $5 | 0.00% |
| JPMorgan Chase & Co | 4 | $3 | 0.00% |
Sold out (2)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 92,585 | $49.1K |
| UBS Group AG | 2,211 | $1.15K |